TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06514027 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06514482 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05402007 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05255406 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05231850 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05239650 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05161585 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05443685 — Predictive Biomarker (PRD): ALDH3A2 mRNA
Genes: ALDH3A2; ALDH10; FALDH
Study NCT05195775 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05390749 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT04773327 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04711239 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05895123 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT06160557 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study NCT06516328 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT05099549 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04368494 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04368494 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04368494 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04688112 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05705856 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study NCT05048680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05307536 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study NCT00000675 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04531592 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05293548 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05604573 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06127147 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06127147 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06351982 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03409081 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04978051 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05659914 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT05659914 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT05659914 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT05659914 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study NCT05361382 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05722366 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04484675 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05833256 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05833256 — Safety Biomarker (SAF): Platelet to lymphocyte
Study NCT04887194 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT05551455 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05494294 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05519670 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06335069 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06181695 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06136351 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05235178 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study NCT05257395 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05257395 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03245424 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06178588 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT05519111 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04902690 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04902690 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04644198 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04644198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04644198 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04644198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06265155 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06491225 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04565912 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05096637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01097603 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01322477 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05042375 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05592028 — Predictive Biomarker (PRD): TAF1 mRNA
Genes: TAF1; BA2R; CCG1; CCGS; TAF2A
Study NCT05493878 — Predictive Biomarker (PRD): ITGA2B mRNA
Genes: ITGA2B; GP2B; ITGAB
Study NCT05493878 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06289387 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT06289387 — Predictive Biomarker (PRD): TM6SF2 mRNA
Genes: TM6SF2
Study NCT06289387 — Predictive Biomarker (PRD): GCKR mRNA
Genes: GCKR
Study NCT06289387 — Predictive Biomarker (PRD): MBOAT7 mRNA
Genes: MBOAT7; BB1; LENG4; OACT7
Study NCT06289387 — Predictive Biomarker (PRD): HSD17B13 mRNA
Genes: HSD17B13; SCDR9; SDR16C3; HMFN0376; UNQ497/PRO1014
Study NCT05198531 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04404101 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06511960 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05424835 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06156878 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05254236 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04545424 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study NCT04545424 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06287489 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04482777 — Predictive Biomarker (PRD): IL37 mRNA
Genes: IL37; FIL1Z; IL1F7; IL1H4; IL1RP1
Study NCT05823038 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05078931 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04850768 — Predictive Biomarker (PRD): NLRC4 mRNA
Genes: NLRC4; CARD12; CLAN; CLAN1; IPAF; UNQ6189/PRO20215
Study NCT05247450 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05837455 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05342012 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study NCT06150508 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05263570 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05263570 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05121298 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT00000696 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02784158 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05865834 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05253755 — Predictive Biomarker (PRD): DBI mRNA
Genes: DBI
Study NCT02523092 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT05234853 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT04997993 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT05166616 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03903549 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC18A2 mRNA
Genes: SLC18A2; SVMT; VMAT2
Study NCT05836831 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06057597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05828615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05712265 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02158767 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06502522 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06107101 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT05937386 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05939245 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT05703425 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT04762992 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT06137885 — Predictive Biomarker (PRD): SHD mRNA
Genes: SHD
Study NCT04819958 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06220994 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06220994 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study NCT05359315 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05165732 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06513611 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04777006 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04967742 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06384846 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05858476 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02919163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05296746 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05296746 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05296746 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05274516 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00002124 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05068505 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05880355 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05769764 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT06448130 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05783570 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT04833335 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT04615624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06307990 — Predictive Biomarker (PRD): THRB mRNA
Genes: THRB; ERBA2; NR1A2; THR1
Study NCT04672980 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04823728 — Predictive Biomarker (PRD): LGI1 mRNA
Genes: LGI1; EPT; UNQ775/PRO1569
Study NCT04823728 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT05595265 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05600985 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05600985 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05141175 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04809519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04884750 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05937685 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00006198 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00006198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04822818 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04822818 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT05551845 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05662124 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04995627 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05023785 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05023785 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05239156 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06129968 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05040997 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT05986227 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05605847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05512182 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05512182 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05512182 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT05512182 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT05512182 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06387381 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06387381 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06188598 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06188598 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05135039 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04719481 — Predictive Biomarker (PRD): IPP mRNA
Genes: IPP; KLHL27
Study NCT06278870 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06278870 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04913142 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05310916 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05124886 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT04313075 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT04729972 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT05425862 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT05395403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05661708 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04826107 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06413095 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05004558 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05004558 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05004558 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05673434 — Predictive Biomarker (PRD): TM4SF1 mRNA
Genes: TM4SF1; M3S1; TAAL6
Study NCT04403789 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06145802 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04646031 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04802382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04802382 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT04802382 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04802382 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04802382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04802382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04802382 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05183516 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05588817 — Predictive Biomarker (PRD): IRAK1 mRNA
Genes: IRAK1; IRAK
Study NCT05917275 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05613088 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study NCT05613088 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT05766462 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05509855 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06374888 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04894019 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05620810 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05946421 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT05271669 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06792344 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06790927 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06778174 — Predictive Biomarker (PRD): ATP8B1 mRNA
Genes: ATP8B1; ATPIC; FIC1; PFIC
Study NCT05333055 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05333055 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06273605 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05585697 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06791512 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06786767 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT06790394 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study NCT05668949 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT06791200 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT06790693 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06790693 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06790693 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06790693 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06792214 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06197152 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT05944809 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05509790 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05509790 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06788938 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study NCT06790420 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06791239 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06791369 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study NCT06791070 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06791707 — Predictive Biomarker (PRD): S100A8 mRNA
Genes: S100A8; CAGA; CFAG; MRP8
Study NCT06791707 — Predictive Biomarker (PRD): Calgranulin B
Genes: S100A9; CAGB; CFAG; MRP14
Study NCT06369285 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06369285 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06369285 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study NCT05715203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06501625 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06791317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06791941 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06791161 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06791161 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06791161 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06791161 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06792604 — Predictive Biomarker (PRD): ZNF582 mRNA
Genes: ZNF582
Study NCT06792604 — Predictive Biomarker (PRD): ASCL1 mRNA
Genes: ASCL1; ASH1; BHLHA46; HASH1
Study NCT06790706 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04916236 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04691648 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06161025 — Predictive Biomarker (PRD): CDH6 mRNA
Genes: CDH6
Study NCT05537740 — Predictive Biomarker (PRD): CCR8 mRNA
Genes: CCR8; CKRL1; CMKBR8; CMKBRL2
Study NCT04614909 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06048120 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06430385 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT04975308 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04975308 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06129188 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04891575 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06403189 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06403189 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT04505358 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72